Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Noninvasive Fetal RhD Blood Group Genotyping: A Systematic Review of Economic Evaluations.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC - 1 Dec 2021

Gajic-Veljanoski Olga, Li Chunmei, Schaink Alexis K, Guo Jennifer, Higgins Caroline, Shehata Nadine, Okun Nanette, de Vrijer Barbra, Pechlivanoglou Petros, Ng Vivian, Sikich Nancy

Abstract excerpt

OBJECTIVE: Noninvasive fetal rhesus D (RhD) blood group genotyping may prevent unnecessary use of anti-D immunoglobulin (RhIG) in non-alloimmunized RhD-negative pregnancies and can guide management of alloimmunized pregnancies. We conducted a systematic review of the economic literature to determine the cost-effectiveness of this intervention over usual care. DATA SOURCES: Systematic literature searches of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cost-Benefit Analysis
Share to Fetal Blood

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotype

Share to Pregnancy

Share to Prenatal Diagnosis

Share to Rh-Hr Blood-Group System

Share to Rh Isoimmunization

Source

Identifiers

PMID: 34390866
DOI: 10.1016/j.jogc.2021.07.014

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Noninvasive Fetal RhD Blood Group Genotyping: A Systematic Review of Economic Evaluations.PMID 34390866Read ↗

Noninvasive Fetal RhD Blood Group Genotyping: A Health Technology Assessment.Semantic proximity Read ↗

Costs and Clinical Outcomes of Noninvasive Fetal RhD Typing for Targeted ProphylaxisSemantic proximity Read ↗

Cost-effectiveness of noninvasive fetal RhD blood group genotyping in nonalloimmunized and alloimmunized pregnancies.Semantic proximity Read ↗

Impact of non-invasive fetal RhD genotyping on management costs of rhesus-D negative patients: results of a French pilot study.Semantic proximity Read ↗

High-throughput, non-invasive prenatal testing for fetal Rhesus D genotype to guide antenatal prophylaxis with anti-D immunoglobulin: a cost-effectiveness analysis.Semantic proximity Read ↗

Non-invasive foetal RhD genotyping: A strategy for rationalizing anti-D immunoglobulin prophylaxis in RhD-negative pregnant women at the Hospital Italiano de Buenos Aires.Semantic proximity Read ↗

Financial implications of RHD genotyping of pregnant women with a serologic weak D phenotypeSemantic proximity Read ↗

A new fetal RHD genotyping test: costs and benefits of mass testing to target antenatal anti-D prophylaxis in England and Wales.Semantic proximity Read ↗

Non-Invasive Prenatal Fetal Blood Group Genotype and Its Application in the Management of Hemolytic Disease of Fetus and Newborn: Systematic Review and Meta-Analysis.Semantic proximity Read ↗

Noninvasive prenatal diagnosis of fetal Rhesus D: ready for Prime(r) Time.Semantic proximity Read ↗

Diagnostic accuracy of noninvasive fetal Rh genotyping from maternal blood--a meta-analysis.Semantic proximity Read ↗

Genotyping to prevent Rh disease: has the time come?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.